Page 7 of 10
The Journal of Organic Chemistry
to 70% EtOAc/hexanes as eluent (35 mg, 88%). 1H NMR (500
(q, J = 7.10 Hz, 2H), 2.14-2.24 (m, 2H), 1.78-1.83 (m, 4H),
1.21-1.28 (m, 6H); 13C NMR (75 MHz, CDCl3) δ 172.4,
138.5, 115.2, 61.6, 59.1, 58.0, 53.7, 47.2, 46.0, 39.1, 38.7, 23.4,
14.0; IR (film) νmax 2925, 2359, 1729, 1255, 1178; HRMS
(ESI) calcd. for C20H31NO4, 350.2287; found, [M+H]+,
350.2281.
1
2
3
4
5
6
7
8
MHz, CDCl3) δ 5.63-5.78 (m, 1H), 5.45-5.55 (m, 2H), 4.94-
5.00 (m, 2H), 4.19 (dq, J = 7.15, 7.03 Hz, 4H), 3.46 (d, J = 2.85
Hz, 2H), 2.94-2.97 (m, 2H), 2.72-2.84 (m, 2H), 2.47 (dd, J =
13.89, 13.89 2H), 2.16-2.24 (m, 2H), 2.15 (s, 3H), 1.20-1.28 (m,
6H); 13C NMR (75 MHz, CDCl3) δ 172.7, 172.4, 139.1,
138.6, 133.7, 129.1, 128.2, 126.9, 115.2, 61.5, 61.5, 59.5, 59.1,
47.3, 46.1, 42.0, 39.2, 38.7, 29.7, 14.1; IR (film) νmax 2925,
2359, 1730, 1453, 1254,; HRMS (ESI) calcd. for C24H33NO4,
[M+H]+, 400.2443; found, 400.2447.
diethyl (E)-3-(3-morpholinoprop-1-en-1-yl)-4-vinylcyclo-
pentane-1,1-dicarboxylate (4f): Prepared following the gen-
eral procedure using Ni(COD)2 (3 mg, 0.01 mmol, 0.05 eq),
dppf (11 mg, 0.02 mmol, 0.1 eq), diethyl 2-((E)-4-hydroxybut-
2-en-1-yl)-2-((E)-penta-2,4-dien-1-yl)malonate (60 mg, 0.2
mmol, 1 eq), morpholine (30 mg, 0.3 mmol, 1.5 eq), and Ti(Oi-
Pr)4 (0.05 mL, 1 eq, 4.879 M solution in toluene) in acetonitrile
(50 µL). The product was obtained as an unseparable mixture
of two diastereomers (4:1) after purification on column using
pure hexanes to 70% EtOAc/hexanes as eluent (33 mg, 46%).
1H NMR (500 MHz, CDCl3) δ 5.60-5.74 (m, 1H), 5.40-5.55 (m,
2H), 4.93-5.08 (m, 2H), 4.19 (q, J = 7.13 Hz, 4H), 3.70 (t, J=
4.64 Hz, 4H), 2.88-3.02 (m, 2H), 2.71-2.83 (m, 2H), 2.43-2.50
(m,2H), 2.33-2.54 (m, 6H), 2.11-2.24 (m, 2H), 1.19-1.29 (m,
6H); 13C NMR (75 MHz, CDCl3) δ 172.6, 172.3, 139.3,
138.5, 134.6, 126.8, 115.5, 115.2, 67.0, 61.6, 59.1, 53.7, 53.5,
49.9, 48.5, 47.2, 46.0, 40.2, 39.9, 39.1, 38.7, 29.7, 14.0; IR
(film) νmax 2926, 2806, 1729, 1453, 1257, 1118; HRMS (ESI)
calcd. for C20H31NO5, [M+H]+, 366.2236; found, 366.2231. Di-
9
diethyl (E)-3-(3-((1-phenylethyl)amino)prop-1-en-1-yl)-4-
vinylcyclopentane-1,1-dicarboxylate (4c): Prepared follow-
ing the general procedure using Ni(COD)2 (1.5 mg, 0.005
mmol, 0.05 eq), dppf (5.5 mg, 0.01 mmol, 0.1 eq), diethyl 2-
((E)-4-hydroxybut-2-en-1-yl)-2-((E)-penta-2,4-dien-1-yl)ma-
lonate (30 mg, 0.1 mmol, 1 eq), 1-phenylethan-1-amine (15 mg,
0.12 mmol, 1.2 eq), and Ti(Oi-Pr)4 (0.03 mL, 1 eq, 4.879 M
solution in toluene) in acetonitrile (50 µL). The product was ob-
tained as an unseparable mixture of two diastereomers (3.5:1)
after purification on column using pure hexanes to 70%
EtOAc/hexanes as eluent (36.3 mg, 91%). 1H NMR (500 MHz,
CDCl3) δ 7.20-7.36 (m, 5H), 5.59-5.75 (m, 1H), 5.29-5.55 (m,
2H), 4.92-5.08 (m, 2H), 4.12-4.23 (m, 4H), 3.78 (q, J = 6.24
Hz,1H), 2.97-3.09 (m, 2H), 2.70-2.79 (m, 2H), 2.37-2.56
(m,2H), 2.10-2.23(m, 2H), 1.34 (d, J = 6.44, 3H), 1.24 (q, J =
6.85, 6H); 13C NMR (75 MHz, CDCl3) δ 172.7, 172.4, 145.5,
138.6, 138.5, 132.1, 129.5, 129.4, 128.4, 126.9, 126.7, 126.6,
115.3, 61.5, 59.1, 57.2, 49.8, 49.3, 48.4, 47.2, 45.9, 40.3, 40.0,
39.1, 39.0, 38.7, 24.2, 21.8, 21.5, 14.0; IR (film) νmax 2924,
1728, 1254, 1178; HRMS (ESI) calcd. for C24H33NO4, [M+H]+,
400.2443; found, 400.2448.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
ethyl
2-((E)-4-morpholinobut-2-en-1-yl)-2-((E)-4-morpho-
linopent-2-en-1-yl)malonate (4h) was isolated as the main by-
product of the reaction as a brown liquid (30 mg, 40%) using
Methanol/EtOAc as eluent. 1H NMR (500 MHz, CDCl3) δ 5.52-
5.65 (m, 1H), 5.41-5.52 (m, 2H), 5.29-5.41 (m, 2H), 4.16 (q, J
= 7.18 Hz, 4H), 3.70 (s, 8H), 2.93 (d, J = 6.33, 2H), 2.75-2.85
(m, 2H) 2.53-2.65 (m, 4H), 2.30-2.52 (m, 8H), 1.20-1.30 (m,
6H), 1.12 (d, J = 6.47, 4H); 13C NMR (75 MHz, CDCl3) δ
170.7, 170.7, 136.9, 131.0, 127.9, 125.5, 67.1, 66.9, 62.7, 61.3,
61.1, 57.6, 53.5, 50.6, 35.4, 17.9, 14.1; IR (film) νmax 2958,
2807, 1731, 1453, 1265, 1200; HRMS (EI) calcd. for
C30H29N3P, [M+H]+, 463.2172; found, 463.2175.
diethyl (E)-3-(3-(piperidin-1-yl)prop-1-en-1-yl)-4-vinylcy-
clopentane-1,1-dicarboxylate (4d): Prepared following the
general procedure using Ni(COD)2 (1.5 mg, 0.005 mmol, 0.05
eq), dppf (5.5 mg, 0.01 mmol, 0.1eq), diethyl 2-((E)-4-hydroxy-
but-2-en-1-yl)-2-((E)-penta-2,4-dien-1-yl)malonate (30 mg, 0.1
mmol, 1 eq), piperidine (11 mg, 0.12 mmol, 1.2 eq), and Ti(Oi-
Pr)4 (0.03 mL, 1 eq, 4.879 M solution in toluene) in acetonitrile
(50 µL). The product was obtained as an unseparable mixture
of two diastereomers (6:1) after purification on column using
pure hexanes to 70% EtOAc/hexanes as eluent (35 mg, 88%).
1H NMR (500 MHz, CDCl3) δ 5.65-5.76 (m, 1H), 5.43-5.54 (m,
2H), 4.93-5.03 (m, 2H), 4.19 (q, J = 8.02, 4H), 2.89-2.93 (m,
2H), 2.71-2.83 (m, 2H), 2.46 (q, J = 7.14 Hz, 2H), 2.27-2.40 (s,
4H), 2.13-2.24(m, 2H), 1.58 (t, J=5.28, 4H), 1.42 (s, 2H), 1.24
(m, 6H); 13C NMR (75 MHz, CDCl3) δ 172.7, 172.4, 138.6,
133.8, 127.6, 115.1, 114.4, 67.5, 61.5, 59.1, 54.3, 47.7, 47.2,
46.0 48.4, 47.2, 45.9, 39.0, 38.7, 24.2, 21.5, 14.0; IR (film)
νmax 2933, 2795, 1730, 1443, 1254,; HRMS (ESI) calcd. for
C21H33NO4, [M+H]+, 364.2443; found, 364.2449.
diethyl (E)-3-(3-(4-methylpiperazin-1-yl)prop-1-en-1-yl)-4-
vinylcyclopentane-1,1-dicarboxylate (4g): Prepared follow-
ing the general procedure using Ni(COD)2 (1.5 mg, 0.005
mmol, 0.05 eq), dppf (5.5 mg, 0.01 mmol, 0.1 eq), diethyl 2-
((E)-4-hydroxybut-2-en-1-yl)-2-((E)-penta-2,4-dien-1-yl)ma-
lonate (30 mg, 0.1 mmol, 1 eq), N-methylpiperazine (15 mg,
0.12 mmol, 1.2 eq), and Ti(Oi-Pr)4 (0.03 mL, 1 eq, 4.879 M so-
lution in toluene) in acetonitrile (50 µL). The product was ob-
tained as an unseparable mixture of two diastereomers (5.8:1)
after purification on column using 10% MeOH/EtOAC as elu-
ent (36.5 mg, 96.5%). 1H NMR (500 MHz, CDCl3) δ 5.60-5.78
(m, 1H), 5.46-5.55 (m, 2H), 4.90-5.06 (m, 2H), 4.19 (q, J = 7.10
Hz, 4H), 2.91-2.98 (m, 2H), 2.71-2.85 (m, 2H), 2.37-2.59 (m,
10H), 2.29 (s, 3H), 2.15-2.24 (m, 2H), 1.19-1.30 (m, 6H); 13
C
diethyl (E)-3-(3-(pyrrolidin-1-yl)prop-1-en-1-yl)-4-vinylcy-
clopentane-1,1-dicarboxylate (4e): Prepared following the
general procedure using Ni(COD)2 (1.5 mg, 0.005 mmol, 0.05
eq), dppf (5.5 mg, 0.01 mmol, 0.1 eq), diethyl 2-((E)-4-hy-
droxybut-2-en-1-yl)-2-((E)-penta-2,4-dien-1-yl)malonate (30
mg, 0.1mmol, 1 eq), pyrrolidine (11 mg, 0.12 mmol, 1.2 eq),
and Ti(Oi-Pr)4 (0.03 mL, 1 eq, 4.879 M solution in toluene) in
acetonitrile (50 µL). The product was obtained as an unsepara-
ble mixture of two diastereomers (4.8:1) after purification on
column using pure hexanes to 70% EtOAc/hexanes as eluent
NMR (300 MHz, CDCl3) δ 172.4, 138.6, 134.3, 127.3, 115.2,
61.6, 61.5, 60.1, 59.1, 55.1, 53.2, 52.9, 47.2, 46.1, 39.1, 38.7,
14.1; IR (film) νmax 2934, 2794, 2359, 1730, 1456, 1256, 1178;
HRMS (ESI) calcd. for C21H34N2O4, 379.2553; found, [M+H]+,
379.2557.
Supporting Information
The Supporting Information is available free of charge on the
ACS Publications website at DOI:
Spectral images for all compounds (PDF)
1
(21 mg, 60%). H NMR (500 MHz, CDCl3) δ 5.63-5.76 (m,
1H), 5.47-5.60 (m, 2H), 4.94-5.07 (m, 2H), 4.19 (q, J = 7.19 Hz,
4H), 3.06-3.15 (m, 2H), 2.71-2.82 (m, 2H), 2.44 (s, 4H), 2.47
Corresponding Author
* dmichaelis@chem.byu.edu
ACS Paragon Plus Environment